ULBP1 Produkte
(UL16 Binding Protein 1 (ULBP1))
Kategorien
Ligand for the NKG2D receptor, together with at least ULBP2 and ULBP3. ULBPs activate multiple signaling pathways in primary NK cells, resulting in the production of cytokines and chemokines. Binding of ULBPs ligands to NKG2D induces calcium mobilization and activation of the JAK2, STAT5, ERK and PI3K kinase/Akt signal transduction pathway. In CMV infected cells, interacts with soluble CMV glycoprotein UL16. The interaction with UL16 blocked the interaction with the NKG2D receptor, providing a mechanism by which CMV infected cells might escape the immune system. UL16 also causes ULBP1 to be retained in the ER and cis- Golgi apparatus so that it does not reach the cell surface.
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte ULBP1 Kategorien
ULBP1 Antikörper
High quality antibodies with extensive validation data.
ULBP1 ELISA Kits
Reliable ELISA kits for a wide range of species.
ULBP1 Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene ULBP1 Antikörper
Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Applikation
ELISA, WB, FACS
Validierungen
- (4)
Kat. Nr.
ABIN7193457
Menge
0.1 mg
Datenblatt
Datenblatt
Reaktivität
Human
Applikation
ELISA, IHC, IF
Validierungen
- (3)
Kat. Nr.
ABIN7174678
Menge
100 μg
Datenblatt
Datenblatt
Reaktivität
Human
Applikation
WB, IHC
Validierungen
- (3)
Kat. Nr.
ABIN6149917
Menge
100 μL
Datenblatt
Datenblatt
Empfohlene ULBP1 ELISA Kits
Produkt
Reaktivität
Analytical Method
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Analytical Method
Quantitative Sandwich ELISA
Validierungen
- (1)
Kat. Nr.
ABIN2703549
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Human
Analytical Method
Semi-Quantitative Sandwich ELISA
Validierungen
Kat. Nr.
ABIN6385012
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Human
Analytical Method
Quantitative Competition ELISA
Validierungen
Kat. Nr.
ABIN1504058
Menge
96 tests
Datenblatt
Datenblatt
Empfohlene ULBP1 Proteine
Produkt
Reaktivität
Source
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Source
HEK-293 Cells
Validierungen
- (3)
Kat. Nr.
ABIN7275817
Menge
100 μg
Datenblatt
Datenblatt
Reaktivität
Human
Source
HEK-293 Cells
Validierungen
- (3)
Kat. Nr.
ABIN7275818
Menge
100 μg
Datenblatt
Datenblatt
Reaktivität
Human
Source
Escherichia coli (E. coli)
Validierungen
- (1)
Kat. Nr.
ABIN7125651
Menge
50 μg
Datenblatt
Datenblatt
Neueste Publikationen zu unseren ULBP1 Produkten
: "Nanoengineered Disruption of Heat Shock Protein 90 Targets Drug-Induced Resistance and Relieves Natural Killer Cell Suppression in Breast Cancer." in: Cancer research, Vol. 80, Issue 23, pp. 5355-5366, (2021) (PubMed).: "Effects of obesity on NK cells in a mouse model of postmenopausal breast cancer." in: Scientific reports, Vol. 10, Issue 1, pp. 20606, (2020) (PubMed).
: "Expression of ligands for activating natural killer cell receptors on cell lines commonly used to assess natural killer cell function." in: BMC immunology, Vol. 20, Issue 1, pp. 8, (2019) (PubMed).
: "NKG2D Regulation of Lung Pathology and Dendritic Cell Function Following Respiratory Syncytial Virus Infection." in: The Journal of infectious diseases, Vol. 218, Issue 11, pp. 1822-1832, (2019) (PubMed).
: "The pharmalogical reactivation of p53 function improves breast tumor cell lysis by granzyme B and NK cells through induction of autophagy." in: Cell death & disease, Vol. 10, Issue 10, pp. 695, (2019) (PubMed).
: "Natural killer cells impede the engraftment of cardiomyocytes derived from induced pluripotent stem cells in syngeneic mouse model." in: Scientific reports, Vol. 9, Issue 1, pp. 10840, (2019) (PubMed).
: "Control of triple-negative breast cancer using ex vivo self-enriched, costimulated NKG2D CAR T cells." in: Journal of hematology & oncology, Vol. 11, Issue 1, pp. 92, (2018) (PubMed).
: "Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 24, Issue 8, pp. 1834-1844, (2018) (PubMed).
: "Immunotherapy of Dual-Function Vector with Both Immunostimulatory and B-Cell Lymphoma 2 (Bcl-2)-Silencing Effects on Gastric Carcinoma." in: Medical science monitor : international medical journal of experimental and clinical research, Vol. 23, pp. 1980-1991, (2017) (PubMed).
: "Expression Profiles of Ligands for Activating Natural Killer Cell Receptors on HIV Infected and Uninfected CD4⁺ T Cells." in: Viruses, Vol. 9, Issue 10, (2017) (PubMed).
Synonyme und alternative Namen zu ULBP1
UL16 binding protein 1 (ULBP1), UL16 binding protein 21 (ULBP21), UL16 binding protein 1 (Ulbp1), NKG2D ligand 1 (LOC100683099), A430108B07Rik, MULT1, RAET1I, ULBP1Bezeichner auf Proteinebene für ULBP1
- N2DL-1
- NKG2D ligand 1
- NKG2DL1
- UL16-binding protein 1
- alcan-beta
- retinoic acid early transcript 1I
- UL16 binding protein 1
- UL16-binding protein-like transcript 1
- NK cell receptor ligand
Sie sind hier:
